| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |